Criminal behavior exacts a large toll on society and is resistant to intervention. Some evidence suggests classic psychedelics may inhibit criminal behavior, but the extent of these effects has not been comprehensively explored. In this study, we tested the relationships of classic psychedelic use and psilocybin use per se with criminal behavior among over 480,000 United States adult respondents pooled from the last 13 available years of the National Survey on Drug Use and Health (2002 through 2014) while controlling for numerous covariates. Lifetime classic psychedelic use was associated with a reduced odds of past year larceny/theft (aOR = 0.73 (0.65–0.83)), past year assault (aOR = 0.88 (0.80–0.97)), past year arrest for a property crime (aOR = 0.78 (0.65–0.95)), and past year arrest for a violent crime (aOR = 0.82 (0.70–0.97)). In contrast, lifetime illicit use of other drugs was, by and large, associated with an increased odds of these outcomes. Lifetime classic psychedelic use, like lifetime illicit use of almost all other substances, was associated with an increased odds of past year drug distribution. Results were consistent with a protective effect of psilocybin for antisocial criminal behavior. These findings contribute to a compelling rationale for the initiation of clinical research with classic psychedelics, including psilocybin, in forensic settings.
Arendsen-HeinGW (1963) LSD in the treatment of criminal psychopaths. In: CrocketRWSandisonRAWalkA (eds) Hallucinogenic Drugs and Their Psychotherapeutic Use. London: H. K. Lewis & Co. Ltd., pp. 101–106.
2.
BogenschutzMPForcehimesAAPommyJAet al. (2015) Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. J Psychopharmacol29: 289–299.
3.
CarbonaroTMBradstreetMPBarrettFSet al. (2016) Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol30: 1268–1278.
4.
Carhart-HarrisRLBolstridgeMRuckerJet al. (2016) Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry3: 619–627.
5.
Carhart-HarrisRLNuttDJ (2013) Experienced drug users assess the relative harms and benefits of drugs: A web-based survey. J Psychoactive Drugs45: 322–328.
6.
ChandlerRKFletcherBWVolkowND (2009) Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. JAMA301: 183–190.
7.
DoblinR (1998) Dr. Leary’s concord prison experiment: A 34-year follow-up study. J Psychoactive Drugs30: 419–426.
8.
DuroseMRCooperADSnyderHN (2014) Recidivism of prisoners released in 30 states in 2005: Patterns from 2005 to 2010. Special Report. Washington, DC: United States Department of Justice, Federal Bureau of Investigation, Criminal Justice Information Services Division. Available at: https://www.bjs.gov/content/pub/pdf/rprts05p0510.pdf
9.
FBI Uniform Crime Report (2015) Crime in the United States 2015. Washington, DC: United States Department of Justice, Federal Bureau of Investigation, Criminal Justice Information Services Division. Available at: https://ucr.fbi.gov/crime-in-the-u.s/2015/crime-in-the-u.s.-2015
10.
FergusonLMWormithJS (2013) A meta-analysis of moral reconation therapy. Int J Offender Ther Comp Criminol57: 1076–1106.
GriffithsRRJohnsonMWCarducciMAet al. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol30: 1181–1197.
13.
HendricksPSClarkCBJohnsonMWet al. (2014) Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. J Psychopharmacol28: 62–66.
14.
HendricksPSThorneCBClarkCBet al. (2015a) Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. J Psychopharmacol29: 280–288.
15.
HendricksPSJohnsonMWGriffithsRR (2015b) Psilocybin, psychological distress, and suicidality. J Psychopharmacol29: 1041–1043.
16.
IoannidisJP (2014) How to make more published research true. PLoS Med: 11: e1001747.
17.
IsbellH (1959) Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacology1: 29–38.
18.
IsbellHBellevilleREFraserHFet al. (1956) Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication. AMA Arch Neurol Psychiatry76: 468–478.
19.
IsbellHLoganCR (1957) Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and resperine on the intensity of the LSD-reaction. AMA Arch Neurol Psychiatry77: 350–358.
20.
IsbellHLoganCRMinerEJ (1959) Studies on lysergic acid diethylamide (LSD-25). III. Attempts to attenuate the LSD-reaction in man by pretreatment with neurohumoral blocking agents. AMA Arch Neurol Psychiatry81: 20–27.
21.
JohansenPØKrebsTS (2015) Psychedelics not linked to mental health problems or suicidal behavior: A population study. J Psychopharmacol29: 270–279.
22.
JohnsonMWGarcia-RomeuACosimanoMPet al. (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol28: 983–992.
23.
JohnsonMWGarcia-RomeuAGriffithsRR (2017) Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse43: 55–60.
24.
KaebleDGlazeLTsoutisAet al. (2016) Correctional populations in the United States, 2014. Washington, DC: United States Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. Available at: https://www.bjs.gov/content/pub/pdf/cpus14.pdf
25.
KrebsTSJohansenPØ (2013) Psychedelics and mental health: A population study. PLoS One8: e63972.
26.
LangtonLTrumanJ (2014) Socio-emotional impact of violent crime. Special Report. Washington, DC: United States Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. Available at: https://www.bjs.gov/content/pub/pdf/sivc.pdf
27.
LearyT (1969) The effects of consciousness-expanding drugs on prisoner rehabilitation. Psychedelic Rev10: 29–45.
28.
LeeMAShlainB (1992) Acid Dreams: The Complete Social History of LSD: The CIA, the Sixties, and Beyond, Revised Edition. New York: Grove Press.
29.
LernerMLyversM (2006) Values and beliefs of psychedelic drug users: A cross-cultural study. J Psychoactive Drugs38: 143–147.
30.
LyversMMeesterM (2012) Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. J Psychoactive Drugs44: 410–417.
31.
McCollisterKEFrenchMTFang (2010) The cost of crime to society: New crime-specific estimates for policy and program evaluation. Drug Alcohol Depend108: 98–109.
32.
MóróLSimonKBárdIet al. (2011) Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users. J Psychoactive Drugs43: 188–198.
NourMMEvansLCarhart-HarrisRL (2017) Psychedelics, personality and political perspectives. J Psychoactive Drugs49: 182–191.
35.
OliverMEStockdaleKCWormithJS (2011) A meta-analysis of predictors of offender treatment attrition and its relationship to recidivism. J Consult Clin Psychol79: 6–21.
36.
Open Science Collaboration (2015) Estimating the reproducibility of psychological science. Science349: aac4716.
37.
ParharKKWormithJSDerkzenDMet al. (2008) Offender coercion in treatment: A meta-analysis of effectiveness. Criminal Justice and Behavior35: 1109–1135.
38.
PearsonFSLiptonDSClelandCMet al. (2002) The effects of behavioral/cognitive-behavioral programs on recidivism. Crime & Delinquency48: 476–496.
39.
PedersenWSkardhamarT (2009) Cannabis and crime: Findings from a longitudinal study. Addiction105: 109–118.
40.
PerryACoultonSGlanvilleJet al. (2006) Interventions for drug-using offenders in the courts, secure establishments and the community. Cochrane Database Syst RevCD005193. doi: 10.1002/14651858.CD005193.pub3.
PiffPKDietzePFeinbergMet al. (2015) Awe, the small self, and prosocial behavior. J Per Soc Psychol108: 883–899.
43.
PisanoVDPutnamNPKramerHMet al. (2017) The association of psychedelic use and opioid use disorders among illicit users in the United States. J Psychopharmacol31: 606–613.
44.
RoomRReuterP (2012) How well do international drug conventions protect public health?Lancet379: 84–91.
45.
RosenbergDEIsbellHMinerEJet al. (1964) The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacology5: 217–277.
46.
RossSBossisAGussJet al. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J Psychopharmacol30: 1165–1180.
47.
SchwalbeCSGearingREMacKenzieMJet al. (2012) A meta-analysis of experimental studies of diversion programs for juvenile offenders. Clin Psychol Rev32: 26–33.
48.
TenenbaumB (1961) Group therapy with LSD-25. (A preliminary report). Dis Nerv Syst22: 459–462.
49.
TrumanJLLangtonL (2015) Criminal Victimization, 2014. Washington, DC: United States Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. Available at: https://www.bjs.gov/content/pub/pdf/cv14.pdf
50.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2003) National Survey on Drug Use and Health, 2002. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
51.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2004) National Survey on Drug Use and Health, 2003. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
52.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2005) National Survey on Drug Use and Health, 2004. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
53.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2006) National Survey on Drug Use and Health, 2005. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
54.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2007) National Survey on Drug Use and Health, 2006. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
55.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2008) National Survey on Drug Use and Health, 2007. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
56.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2009) National Survey on Drug Use and Health, 2008. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
57.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2010) National Survey on Drug Use and Health, 2009. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
58.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2011) National Survey on Drug Use and Health, 2010. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
59.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2012) National Survey on Drug Use and Health, 2011. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
60.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2013) National Survey on Drug Use and Health, 2012. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
61.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2014) National Survey on Drug Use and Health, 2013. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
62.
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2015) National Survey on Drug Use and Health, 2014. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
63.
VisherCAWinterfieldLCoggeshallMB (2005) Ex-offender employment programs and recidivism: A meta-analysis. Journal of Experimental Criminology1: 295–316.
64.
WalshZHendricksPSSmithSet al. (2016) Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. J Psychopharmcol30: 601–607.
65.
WilliamsR (2006) Generalized ordered logit/partial proportional odds models for ordinal dependent variables. Stata Journal6: 58–82.
66.
WilliamsR (2016) Understanding and interpreting generalized ordered logit models. The Journal of Mathematical Sociology40: 7–20.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
